Mouse Wound Models and Preparation of Single-Cell Suspensions

Summary

This study presents two crucial experimental techniques: the construction of a murine wound model for assessing wound closure and the preparation of single-cell suspensions from murine skin to preserve cellular viability.

Abstract

The management of acute full-thickness skin injuries presents a considerable challenge in clinical practice. The complexity of wound healing, involving diverse cell populations and the intricate wound microenvironment, complicates the assessment of treatment effects and their interactions using traditional experimental approaches. Single-cell transcriptome sequencing technology has revolutionized the understanding of cellular functions and mechanisms during wound healing. However, the variability in methodologies for creating mouse wound models introduces confounding factors that can impact experimental results. Furthermore, the process of dissociating mouse skin tissues presents significant technical hurdles, highlighting the critical need for high-quality single-cell suspensions for accurate transcriptome sequencing. Therefore, this study aims to optimize the construction of mouse wound models to accurately assess changes in wound closure while eliminating variables that could influence the subsequent sequencing result. Additionally, the preparation of single-cell suspensions was performed using both enzyme preparation protocols and test kit protocols to optimize cost and effectiveness.

Introduction

The mouse is a widely recognized animal model in research for its highly homologous genetic sequence to humans, rapid reproduction, cost-effectiveness, and manageable size¹. However, differences exist in the skin structure between mice and humans. Mice have a distinct cutaneous membrane layer that contributes to skin contraction, playing a crucial role in wound healing in this species. In contrast, human wound healing primarily involves re-epithelialization and granulation tissue formation¹.

Despite these interspecies differences in skin structure, the mouse model remains the preferred choice in wound repair research and retains significant importance compared to other animal models^2,3. When using mouse skin to mimic human wound healing processes, careful consideration of various influencing factors is essential. These factors include selecting appropriate sites for surgical procedures, accounting for the mouse hair follicle cycle, and understanding the effects of cutaneous membrane contraction^4,5. Implementing corresponding measures is vital to optimizing experimental conditions and improving the accuracy of observational outcomes.

Single-cell RNA sequencing (scRNA-seq) sequences cells at a much more refined level than conventional RNA sequencing and has a much higher requirement for sample quality with minimal intragroup differences. Multiple experiments were conducted to refine a stable mouse acute full-thickness skin defect model. These experiments utilized a combination of established methods from literature and innovative approaches to evaluate wound healing comprehensively^2,5. To develop the wound healing model, mouse full-thickness skin excision was used to replicate the physiological process of wound repair and regeneration. Its objective was to assess the potential alterations induced by various treatments using scRNA-seq. Skin tissue dissociation from mice poses challenges, including low cell viability and high aggregation rates, during the preparation of single-cell suspensions⁶. These difficulties may result in issues like instrument clogging and anomalous cell capture, which can compromise data quality. Given the considerable cost of single-cell sequencing, conducting multiple preliminary experiments is crucial to ensure the stability and reliability of the single-cell suspension. This study assessed the efficacy of mixed enzyme dissociation and the tissue kit dissociation method to identify the optimal approach for tissue dissociation^6,7. This study establishes a robust foundation for further in-depth investigations.

Protocol

All procedures were approved by the Ethics Committee of the seventh Medical Center of Chinese PLA General Hospital, China. Male C57/BL6 mice aged 6 weeks were used. 

1. Mouse wound healing model

1. Animal grouping
   1. Randomly assign mice to experimental and control groups (6 each). House mice in a specific pathogen-free (SPF) animal facility, with a temperature maintained at 23-25 °C, humidity at 50%-60%, and a 12 h light-dark cycle.
   2. Provide mice with unrestricted access to standard food and autoclaved tap water.
2. Preoperative preparation
   1. Gently restrain the mouse using a restrainer or by holding the mouse securely in a prone position. Load the syringe with 1% pentobarbital sodium restored to room temperature, administered at a dose of 0.1 mL/20 g body weight.
      NOTE: The 1% pentobarbital sodium solution should be stored in a dark environment at 4 °C.
   2. Clean the mouse's abdomen with alcohol cotton swabs. Insert the syringe at a slight angle into the abdomen. Aspirate before injection to prevent inadvertent administration into the bladder or intestines. Wait for 10 min.
   3. After the mouse stops twitching and no longer responds to stimuli, apply white petrolatum to both eyes to prevent dryness. Use a shaver to trim longer dorsal fur.
   4. Apply depilatory cream to the back, wait for 2 min, and gently wipe away with moist gauze to avoid damaging the mouse's skin. Ensure the depilatory cream is not left on for an extended period.
   5. Gently disinfect the surrounding skin with three alternating swabs of betadine and 70% alcohol.
   6. Autoclave skin biopsy punch, scissors, forceps, and other instruments for sterilization. Maintain a sterile workspace. Perform subsequent surgery on a fresh surgical cloth.
3. Full-thickness skin excision
   NOTE: The wound splint model was used to assess the effectiveness of treatment for wound healing.
   1. Using a permanent marker, mark the upper central area of the mouse's dorsal region with one 8-mm-diameter circle.
   2. Lift the dorsal skin using clean forceps and make the first cut using fine surgical scissors. Following the first cut, hold the partially removed skin area using forceps and carefully cut out the marked circles.
   3. Use a custom-designed stainless-steel ring (internal diameter 15 mm, external diameter 18 mm). Suture the metal ring to the periphery of the incision site with 5-0 non-absorbable sutures, preventing contraction of the incision site skin (Figure 1A). Use stainless steel as the ring material to prevent rusting and deformation.
   4. Administer a single 0.1 mL subcutaneous injection of 10% buprenorphine hydrochloride dilution near the wound to treat post-surgical pain.
   5. Reintroduce the mouse to clean individual cages. Place the mouse in a prone position. Do not leave the mouse unattended before the mouse regains consciousness.
   6. Observe and photograph the mouse wound every 2 days to measure the wound size following anesthesia as described in step 1.2.
4. Wound stamp marking to obtain biopsy tissue
   1. Prepare for the experiment as described in steps 1.1 and 1.2.
   2. Create customized mouse wound marking stamps with a circle diameter of 8 mm and a square side length of 10 mm (Figure 1B).
   3. Position the mouse in a prone posture and disinfect the dorsal skin with alcohol cotton swabs. Dip the stamp in ink. Make a mark on the upper-middle part of the mouse's back with the stamp.
   4. Carefully excise the entire skin layer of the back along the circular mark using surgical scissors, exposing the muscle layer completely. Leave the wound open without dressing to avoid interfering with the wound's state. Maintain the sterility of the wound by placing the mouse in a clean and disinfected environment and allowing the wound to naturally form a scab.
   5. Administer a single 0.1 mL subcutaneous injection of 10% buprenorphine hydrochloride dilution near the wound to treat post-surgical pain.
   6. Reintroduce the mouse to clean individual cages. Place the mouse in a prone position. Do not leave the mouse unattended before the mouse regains consciousness.
   7. Observe and photograph the mouse wound every 2 days to measure wound size following anesthesia as described in step 1.2.
   8. Perform treatment administration as described in 1.4
5. Treatment administration
   1. At 4 h after the mouse regains consciousness, perform anesthesia as described in steps 1.2.2-1.2.3.
   2. Subcutaneously inject the desired treatment, here 100 µg of human umbilical cord mesenchymal stem cell-derived exosome (hucMSC-Exo) dissolved in 200 µL of PBS around the incision site for the treatment group.
   3. Subcutaneously inject 200 µL of PBS around the incision site for the control group.
   4. Repeat steps 1.5.2 and 1.5.3 every two days for up to 14 days. Inspect the injection site for any swelling, redness, or signs of infection.

2. Preparation for single-cell RNA sequencing

1. Tissue collection and preparation
   1. Perform anesthesia as described in steps 1.2.2-1.2.3.
   2. Lift the dorsal skin using clean forceps and remove the scabs. Cut off roughly 2 cm² of skin near the wound, trimming off adipose tissue and large blood vessels.
   3. Transfer skin biopsy with sterile forceps into a well of a 6-well plate filled with pre-chilled 4 mL of PBS.
   4. Wash with PBS by sequentially transferring the biopsy into new wells (6-well plate) filled with 4 mL of PBS until no visible blood is present.
   5. Cut the skin with a scalpel into approximately 2 mm-sized pieces, further washing in DPBS containing 0.04% BSA and removing any debris.
2. Enzymatic dissociation (Figure 2)
   1. Combine 1 mL of Collagenase I (10 mg/mL), 1 mL of Collagenase IV (5 mg/mL), 1 mL of Collagenase D + Dispase II (15 mg/mL), 1 mL of DNase I (5 mg/mL), and 6 mL of DPBS in a sterile conical tube to prepare the digestion solution. Thoroughly mix the components to ensure homogeneity.
   2. Place the conical tube in a water bath set at 37 °C for 10 min to preheat the digestion solution.
   3. Add 2.5 mL of digestion solution to the tissue and digest at 37 °C for 70 min, flipping the test tube every 10 min for thorough mixing.
   4. Pre-wet a 70 µm strainer with washing buffer (0.2% BSA in PBS). Transfer the reaction mix, including dissociated cells and residual tissue fragments, using a 1 mL wide-bore pipette tip on the strainer.
   5. Filter this mixture through the pre-wet 70 µm cell strainer into a 15 mL centrifuge tube.
   6. Centrifuge the reaction mixture with digested tissue at 300 x g, room temperature for 5 min. Discard the supernatant and keep the pellet (cells) for the next dissociation step.
3. Red blood cell lysis
   1. Dilute red blood cell lysis solution (10x) at a 1:10 ratio with double-distilled water. Dilute the cells with 1x red blood cell lysis solution in a 1:10 ratio in a conical tube.
   2. Vortex the mixture for 5 s, incubate at room temperature for 2 min and then centrifuge at 300 x g for 5 min. Aspirate the supernatant, resuspend the cells in equal volume DPBS, and store them on ice.
4. Filtration
   1. Retrieve the cell suspension and filter it through a 40 µm strainer into a new conical tube.
   2. Rinse the tube 2x with 4.5 mL of RPMI (10% FCS) to ensure the collection of any remaining cells.
   3. Proceed to centrifuge the cell suspension at 300 x g at room temperature for 5 min.
   4. Discard the supernatant, gently flick the pellet, and resuspend the cells with wide-bore tips in 50 µL of 0.04% BSA PBS. Maintain the cells on ice throughout this process.
5. Dead cell removal
   1. Mix the dead cell removal kit 20x stock buffer with nuclease-free water in a 1:20 ratio to obtain a 1x binding buffer.
   2. Centrifuge the sample at 300 x g, remove the supernatant, and add 10 µL of dead cell removal microbeads for 60 mg of skin sample.
   3. Incubate for 15 min at room temperature. Add stock buffer until it reaches 500 µL. Load the sample into the prepared column in the kit and attach it to the dissociator.
   4. Run the dissociator program to separate live cells. After the program terminates, filter the suspension through a 30 µm filter and dilute it with equal volume D-PBS.
      NOTE: If the dripping speed noticeably slows down, promptly replace the column to prevent impurities from blocking the pores and affecting cell recovery.
   5. Perform Acridine Orange/Propidium Iodide (AO/PI) staining and cell counting using an automated cell counter. Use the following acceptance criteria: cell viability ≥ 85%, cell aggregation rate < 20%, and no visible red blood cells or cell fragments.
6. Dissociation procedure for the multi-tissue dissociation kit (Alternative)
   1. Mix 2.5 mL of RPMI 1640, 100 µL of Enzyme D, 50 µL of Enzyme R, and 12.5 µL of Enzyme A1 into a gentle MACS C tube (components from the Multi Tissue Dissociation Kit).
   2. Transfer the tissue into the gentle MACS C tube containing the enzyme mix and tightly close it.
   3. Place the tube at 37 °C in a water bath for 90 min with gentle inversion every 10 min to ensure adequate tissue exposure to the dissociation solution.
   4. Discard the dissociation solution and wash the tissues with DPBS.
   5. Pass single-cell suspensions through 70 µm and 40 µm cell strainers sequentially and centrifuge at 4 °C for 10 min at 300 x g.
   6. Lyse red blood cells using the red blood cell lysis reagent following the same procedure as step 2.3.
   7. Remove dead cells using the dead cell removal kit following the same procedure as in step 2.5⁸.
   8. Perform AO/PI staining and cell counting using an automated cell counter. Use the following acceptance criteria: cell viability ≥ 85%, cell aggregation rate < 20%, and no visible red blood cells or cell fragments.

Results

Multiple variations of the procedure were explored. Stamp protocols were preferred as they contain minimal interference to the wound healing process and maintain wound integrity from influences such as scratching and sutures. This is to avoid introducing noise at a single-cell level for the subsequent sequencing. Placing wounds on both sides of a mouse resulted in noticeable differences in wound area due to the inherent elasticity of mouse skin (Figure 3A,B). Bilateral punct...

Discussion

Several crucial steps were essential for the protocol's success. These steps included precise preparation of the wound area by thorough shaving and cleaning, creating standardized wounds of specific size and depth, and diligent post-wound care to monitor infections and administer appropriate treatments. Standardization of these procedures ensured consistency across experimental conditions, thereby enhancing the reliability and reproducibility of results¹⁰.

We employed w...

Materials

Name	Company	Catalog Number	Comments
75% Alcolchol	Liuhe	JIUJING500ML
C57/BL6J mice	Charles River Laboratories
Collagenase D + Dispase II	Roche	11088858001
Collagenase I	Roche	5349907103
Collagenase IV	Roche	5267439001
Cotton Swabs	Haishi	MIANQIAN
Dead Cell Removal Kit	Miltenyi Biotec	130-090-10
DNase I	Roche	10104159001
gentleMAC Dissociator	Miltenyi Biotec	130-093-235
Medical nylon thread	Jinlong	HM507
Multi Tissue Dissociation Kit 1	Miltenyi Biotec	130-110-201
punch biopsy needle	Integra Miltex
red blood cell lysis solution	Miltenyi Biotec	130-094-183
Surgical Scissor	Jinglu	JIANDAO
White petrolatum	Shangyuan	BAIFANSHILIN